The effect of electrode size on transvenous defibrillation energy requirements: A prospective evaluation

PACE - Pacing and Clinical Electrophysiology

Volumn 20, Issue 4 I, 1997, Pages 893-898

  Halperin, Blair D ^a   Reynolds, Brian ^a   Fain, Eric S ^a   Ligon, David A ^a   Silka, Michael J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

defibrillation; implantable defibrillators; transvenous leads; ventricular fibrillation

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEFIBRILLATION; DEFIBRILLATOR; DOG; ENERGY RESOURCE; HEART VENTRICLE FIBRILLATION; NONHUMAN; PACEMAKER ELECTRODE; PROSPECTIVE STUDY; THORACOTOMY; TREATMENT OUTCOME; WAVEFORM;

ANIMALS; CARDIAC PACING, ARTIFICIAL; DEFIBRILLATORS, IMPLANTABLE; DOGS; ELECTRODES, IMPLANTED; EQUIPMENT DESIGN; PROSPECTIVE STUDIES; VENTRICULAR FIBRILLATION;

EID: 0030948403     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1997.tb05491.x     Document Type: Article

References (19)

1. Chapman PD, Sagar KB, Wetherbee JN, et al. Relationship of left ventricular mass to defibrillation threshold for the implantable defibrillator: A combined clinical and animal study. Am Heart J 1987; 114:274-278.
2. Echt DS, Cato EL, Cox DR. pH-dependent effects of lidocaine on defibrillation energy requirements in dogs. Circulation 1989; 80: 1003-1009.
3. Halperin BD, Haupt DW, Lemmer JH, et al. Early changes in defibrillation threshold following implantation of a nonthoracotomy system in dogs. PACE 1994; 17:1771-1777.
4. Choi SC. Interval estimation of the LD50 based on an up-and-down experiment. Biometrics 1990; 46: 485-492.
5. Norenberg MS, Sakun V, Roberts D, et al., and the Worldwide PCD Investigators. Long-term clinical experience with PCD Transvene system: Worldwide experience. PACE 1993; 16:874A.
6. Venditti FJ, Martin DT, Shahian D. The CPI Endotak nonthoracotomy lead system. In NA Estes, AS Manolis, PJ Wang (eds.): Implantable Cardioverter-Defibrillators. New York, NY, Marcel Decker, Inc., 1994, pp. 779-794.
7. Mattioni T, Riggio D, for the Cadence TVL Investigators. Initial clinical experience with a new non-thoracotomy cardioverter-defibrillator lead system. Circulation 1994; 90:1123A.
8. Bardy GH, Poole JE, Kudenchuck PJ, et al. A prospective randomized comparison in humans of biphasic waveform 60-μF and 120-μF capacitance pulses using a unipolar defibrillation system. Circulation 1995; 91:91-95.
9. Lerman BB, Weiss JL, Bulkley BH, et al. Myocardial injury and induction of arrhythmia by direct current shock delivered via endocardial catheters in dogs. Circulation 1984; 69: 1006-1012.
10. Epstein AE, Anderson PG, Shepard RB, et al. Gross and microscopic pathologic changes associated with nonthoracotomy implantable defibrillator leads. Circulation 1994; 90:122A.
11. Connell PN, Ewy GA, Dahl CF, et al. Transthoracic impedance to defibrillator discharge. Effect of electrode size and electrode-chost wall interface. J Eloctrocardiol 1973; 6:313-317.
12. Dixon EG, Tang ASL, Wolf PD, et al. Improved defibrillation thresholds with large contoured epicardial electrodes and biphasic waveforms. Circulation 1987; 76:1176-1184.
13. Troup PJ, Chapman PD, Olinger GN, et al. The implanted defibrillator: Relation of defibrillating lead configuration and clinical variables to defibrillation threshold. J Am Coll Cardiol 1985; 6: 1315-1321.
14. Oyama K, Lee R, Ott GY, et al. Cardiac histopathology associated with nonthoracotomy lead systems. Circulation 1994; 90:122A.
15. Lang DL, Heil JE, Hahn SJ, et al. Implantable cardioverter-defibrillator lead technology: Improved performance and lower defibrillation thresholds. PACE 1995; 18[Pt. II]:548-559.
16. Ideker RE, Wolf PD, Alferness C, et al. Current concepts for selecting the location, size and shape of defibrillation electrodes. PACE 1991; 14:227-240.
17. Bardy GH, Johnson G, Poole JE, et al. A simplified, single-lead unipolar transvenous cardioversion-dofibrillation system. Circulation 1993; 88: 543-547.
18. Kudenchuck PJ, Bardy GH, Dolack GL, et al. Efficacy of a single-lead unipolar transvenous defibrillator compared with a system employing an additional coronary sinus electrode: A prospective, randomized study. Circulation 1994; 89: 2641-2644.
19. Bardy GH, Dolack GL, Kudenchuck PJ, et al. Prospective, randomized comparison in humans of a unipolar defibrillation system with that using an additional superior vena cava electrode. Circulation 1994; 89:1090-1093.